Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hepatitis

  Free Subscription


19.02.2024

1 Arch Virol
1 BMC Gastroenterol
2 Dig Dis Sci
2 Gastroenterol Hepatol
1 Gastroenterology
1 Hepatology
1 Int J Cancer
2 J Hepatol
1 J Med Virol
1 J Viral Hepat
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Transplant Proc
1 Transplantation
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. SAID EM, Abdulaziz BA, Kassas ME, El Attar IH, et al
    Retraction Note: High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir the
    Arch Virol. 2024;169:45.
    PubMed        


    BMC Gastroenterol

  2. ZHOU Y, Liang M, Li Y, Chen X, et al
    Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.
    BMC Gastroenterol. 2024;24:73.
    PubMed         Abstract available


    Dig Dis Sci

  3. HUANG J, Cheng C, Li K, Zhu C, et al
    Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08258.
    PubMed         Abstract available

  4. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    PubMed         Abstract available


    Gastroenterol Hepatol

  5. JORQUERA F, Ledesma F, Ahumada A, Manzano ML, et al
    Clinical profile of Spanish hepatitis C virus-infected treatment-naive patients with compensated cirrhosis in the CREST study.
    Gastroenterol Hepatol. 2024 Feb 12:S0210-5705(24)00037.
    PubMed         Abstract available

  6. LIU Y, Chen S, Yu S, Wang J, et al
    LPS-TLR4 pathway exaggerates alcoholic hepatitis via provoking NETs formation.
    Gastroenterol Hepatol. 2024;47:158-169.
    PubMed         Abstract available


    Gastroenterology

  7. TRIVEDI PJ, Hirschfield GM, Adams DH, Vierling JM, et al
    Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.
    Gastroenterology. 2024 Feb 9:S0016-5085(24)00165.
    PubMed         Abstract available


    Hepatology

  8. MOCTEZUMA-VELAZQUEZ C, Wong YJ, Montano-Loza AJ
    Editorial: Promise and pitfalls of a natural killer cell signature for hepatocellular carcinoma detection in HCV patients with sustained virological response.
    Hepatology. 2024 Feb 14. doi: 10.1097/HEP.0000000000000797.
    PubMed        


    Int J Cancer

  9. KARTSONAKI C, Yao P, Butt J, Jeske R, et al
    Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
    Int J Cancer. 2024;154:1423-1432.
    PubMed         Abstract available


    J Hepatol

  10. YANG H, Jang JW
    Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!'.
    J Hepatol. 2024 Feb 10:S0168-8278(24)00123-5. doi: 10.1016/j.jhep.2024.
    PubMed        

  11. GAWRIEH S, Dasarathy S, Tu W, Kamath PS, et al
    Randomized-controlled trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.
    J Hepatol. 2024 Feb 9:S0168-8278(24)00109-0. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available


    J Med Virol

  12. BLANCO S, Castro GM, Sicilia PE, Carrizo LH, et al
    Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An emerging threat for transfusion safety in low-endemic countries?
    J Med Virol. 2024;96:e29463.
    PubMed         Abstract available


    J Viral Hepat

  13. NING Q, Yang T, Guo X, Huang Y, et al
    CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes.
    J Viral Hepat. 2023;30:951-958.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  14. QURESHI NS, Villatoro AJ, Tran NDT, Herrera SJ, et al
    Hepatitis A Exposure Response and Outbreak Prevention in a Large Urban Jail - Los Angeles County, California, May-July 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:131-134.
    PubMed         Abstract available


    N Engl J Med

  15. WANDERA N, Olds P, Muhindo R, Ivers L, et al
    Rift Valley Fever - The Need for an Integrated Response.
    N Engl J Med. 2023;389:1829-1832.
    PubMed        


    PLoS One

  16. MODIYINJI AF, Tankeu LTA, Monamele CG, Yifomnjou Moumbeket MH, et al
    Hepatitis E virus infections among patients with acute febrile jaundice in two regions of Cameroon: First molecular characterization of hepatitis E virus genotype 4.
    PLoS One. 2024;19:e0298723.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  17. KOONIN EV
    Circular RNAs from linear viral RNA genomes: A distinct dimension in the virus world.
    Proc Natl Acad Sci U S A. 2024;121:e2401335121.
    PubMed        


    Transplant Proc

  18. PARK JH, Shin YH, Chang WB
    An Anatomically Complicated Living Donor Kidney Transplantation from Hepatitis B Surface Antigen-Positive Donor to Negative Recipient With Size Discrepancy.
    Transplant Proc. 2024 Feb 10:S0041-1345(24)00017.
    PubMed         Abstract available


    Transplantation

  19. PATEL SS, Kim JI, Stewart DE, Segev DL, et al
    Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission.
    Transplantation. 2024 Feb 16. doi: 10.1097/TP.0000000000004929.
    PubMed         Abstract available


    Vaccine

  20. SANTORO PE, Paladini A, Borrelli I, Amantea C, et al
    Vaccine-preventable diseases: Immune response in a large population of healthcare students.
    Vaccine. 2024 Jan 20:S0264-410X(24)00049-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.